- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 23
Scalable Capital mounts $58m series D campaign
Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.
Jul 23, 2020Dexterity has a knack for funding
Dexterity, a logistics robot spinout of Stanford, has emerged from stealth with series A funding and debt financing from Stanford-StartX Fund.
Jul 23, 2020Cerevance captures $65m series B
UPMC Enterprises has contributed to a $20m series B extension for Cerevance, which is commercialising Rockefeller University research.
Jul 22, 2020Spin Memory executes extra series B cash
NYU-founded Spin Memory has now raised $60.3m in series B capital, having lured the return of Allied Minds, Arm and Applied Ventures.
Jul 20, 2020Glympse Bio gleans series B funding
Section 32 has led a $46.7m series B round that will support further development of the MIT spinout's biosensor-based diagnostics device.
Jul 17, 2020Paige pings investors for extra series B cash
Memorial Sloan Kettering spinout Paige’s series B total stands at $70m following a third tranche featuring Goldman Sachs and Healthcare Venture Partners.
Jul 13, 2020Nine Square sides with ATP for $50m series A
UCSF has unveiled Nine Square Therapeutics with $50m in series A capital from founding investor Apple Tree Partners.
Jul 7, 2020Evidation Health generates $45m results
McKesson Ventures came onboard for the health data provider Evidation's series D round, helping it hike its overall funding to $106m five years after being co-founded by Stanford Health Care.
Jul 3, 2020XSky stores $45.3m series D
Cloud storage provider XSky pushed its funding haul to $38m after securing the return of a Tsinghua University's fund management affiliate.
Jul 3, 2020Bolt latches onto $93.5m series C
Novo, Pfizer and Nan Fung helped provide $93.5m for the Stanford immunotherapy spinout as it advances its lead asset towards the clinic.
Jul 2, 2020
About us
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.